# Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women

> **NCT00256217** · PHASE2 · COMPLETED · sponsor: **Rita Sanghvi, Mehta** · enrollment: 42 (actual)

## Conditions studied

- DCIS

## Interventions

- **DRUG:** Anastrozole

## Key facts

- **NCT ID:** NCT00256217
- **Lead sponsor:** Rita Sanghvi, Mehta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09-21
- **Primary completion:** 2018-12-12
- **Final completion:** 2018-12-12
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2021-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00256217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00256217, "Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00256217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*